Abstract
Inhalation therapy, which is regarded as highly effective administration methodology for various pulmonary diseases, can be more fascinating by employing liposomal technology. Clinical studies on liposomal inhalable formulations are already ongoing, and thus they may become available in near future. In this review, recent results on the formulation development studies and current status on their clinical applications are summarized.